Association of polymorphisms in folate metabolic genes and prostate cancer risk: a case-control study in a Chinese population.
Cai
Dawei
D
Department of Urology, Shengjing Hospital of China Medical University, Shenyang, People's Republic of China.
Ning
Lin
L
Pan
Chunyu
C
Liu
Xuefeng
X
Bu
Renge
R
Chen
Xiaonan
X
Wang
Kefeng
K
Cheng
Yang
Y
Wu
Bin
B
D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase / Q000235:genetics*; D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D016022:Case-Control Studies; D002681:China / Q000453:epidemiology; D005287:Ferredoxin-NADP Reductase / Q000235:genetics*; D005492:Folic Acid / Q000378:metabolism; D008040:Genetic Linkage; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011470:Prostatic Hyperplasia / Q000235:genetics; D011471:Prostatic Neoplasms / Q000235:genetics*
D005492:Folic Acid; C111241:methionine synthase reductase; D005287:Ferredoxin-NADP Reductase; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase